LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Your last searches

  1. AU="Peiró Morant, J"
  2. AU="Dário Dantas do Amaral"
  3. AU="Al-Malkey, Maysaa Kadhim"
  4. AU="Barlow, Katherine"
  5. AU=Leti Fatjon
  6. AU="Guo, Zhikun"
  7. AU=Germani Antonia
  8. AU=Erdmann Weronika
  9. AU="Mundil, Robert"
  10. AU="Shi, Nanxi"
  11. AU="Hou, Guo-jiang"
  12. AU="Toma G."
  13. AU="Ramlan"
  14. AU="Hughes, Evan"
  15. AU="Putzeys, Leena"
  16. AU="Levchenko, Polina"
  17. AU=Kucia M AU=Kucia M
  18. AU="Abbad, Sofia"
  19. AU="Bormans, Guy"
  20. AU="Güven, Onur"
  21. AU="Harding, C. V"
  22. AU="Tadono, Takeo"
  23. AU="Pethani, Jignesh P"
  24. AU="Yilmaz, Hayriye"
  25. AU="Brooks, Joanna M"
  26. AU="Bogan, C"
  27. AU="Acevedo, David"
  28. AU="Runjhun, Rashmi"
  29. AU="McGettigan, Benjamin"
  30. AU="Do, Xuan Long"
  31. AU="Hadváry, P"
  32. AU="M.Vas'uth, "
  33. AU="Aliev, Gjumrakch"
  34. AU="Kędziora, Kamila"
  35. AU=Petralia Ronald S.
  36. AU="Shirwaiker, Rohan A"
  37. AU="Heitkamp, Sara"

Search results

Result 1 - 7 of total 7

Search options

  1. Article ; Online: Conocimiento de la tromboprofilaxis-COVID-19 en los profesionales sanitarios en España.

    García Vallejo, O / Frías Vargas, M / Gil Gil, I / Vázquez Gómez, N / Piera Carbonell, A / Peiró Morant, J

    Semergen

    2021  Volume 47, Issue 6, Page(s) 361–368

    Abstract: Introduction: Patients suffering from coronavirus infection have an increased risk of venous thromboembolic disease (VTE) associated with COVID-19, which confers a higher risk of mortality. For this reason, it is necessary to analyze the knowledge and ... ...

    Title translation Knowledge of thromboprophylaxis-COVID-19 in healthcare professionals in Spain.
    Abstract Introduction: Patients suffering from coronavirus infection have an increased risk of venous thromboembolic disease (VTE) associated with COVID-19, which confers a higher risk of mortality. For this reason, it is necessary to analyze the knowledge and the different actions in the management of thromboprophylaxis in work environments.
    Material and methods: Observational, descriptive and cross-sectional study with data collection through a Google® form with 19 questions for professionals involved in the care of COVID-19. 414 surveys were received. The quantitative variables were represented with means and standard deviation and the qualitative variables with percentages and confidence intervals.
    Results: 414 surveys analyzed. 58.2% were women. The most participatory age group was 56-65 years. 95.2% stated that COVID-19 patients had a higher risk of VTE and peripheral arterial microthrombosis. 93.6% considered that outpatient COVID-19 patients should receive thromboprophylaxis. 60.5% of the physicians did not know any protocol for the evaluation of thrombotic risk in these patients. Low molecular weight heparin was considered the main treatment for thromboprophylaxis.
    Conclusions: The majority of doctors consider that COVID-19 patients have a higher risk of suffering VTE and peripheral arterial microthrombosis than the general population, however more than a third do not assess the thrombotic risk and a significant percentage claim not to know protocols to evaluate said risk. The survey highlights the training needs of our professionals in thromboprophylaxis so that our patients receive healthcare with the highest possible quality.
    MeSH term(s) Aged ; Anticoagulants ; COVID-19 ; Cross-Sectional Studies ; Delivery of Health Care ; Female ; Humans ; Male ; Middle Aged ; SARS-CoV-2 ; Spain ; Venous Thromboembolism/epidemiology ; Venous Thromboembolism/prevention & control
    Chemical Substances Anticoagulants
    Language Spanish
    Publishing date 2021-03-08
    Publishing country Spain
    Document type Journal Article ; Observational Study
    ISSN 1578-8865
    ISSN (online) 1578-8865
    DOI 10.1016/j.semerg.2021.01.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Conocimiento de la enfermedad venosa crónica en los profesionales sanitarios en España.

    Peiró Morant, J F / Ramírez Torres, J M / Pérez Vázquez, E / Lozano Bouzón, V M / Parra Valderrama, A / Frías Vargas, M

    Semergen

    2023  Volume 49, Issue 8, Page(s) 102063

    Abstract: Introduction: Chronic venous disease (CVD) is classified as the most prevalent vascular disease in humans. It has been associated with an increased incidence of cardiovascular diseases and is a strong predictor of all-cause mortality, representing a ... ...

    Title translation Knowledge of chronic venous disease among healthcare professionals in Spain.
    Abstract Introduction: Chronic venous disease (CVD) is classified as the most prevalent vascular disease in humans. It has been associated with an increased incidence of cardiovascular diseases and is a strong predictor of all-cause mortality, representing a public health problem of the first magnitude. The objective of this study was to analyze the actions in the management of CVD in the daily clinical practice of health professionals in Spain.
    Material and methods: Observational, descriptive and cross-sectional study with data collection through an opinion survey of 22 questions completed electronically through a Google® form for professionals involved in chronic venous disease care. Three hundred surveys were analyzed. The quantitative variables were represented with means and standard deviation and the qualitative ones with percentages and confidence intervals.
    Results: Three hundred surveys analyzed. 65.3% were women. The most participatory age group was over 55 years of age. 85% of those surveyed considered that CVD is an underdiagnosed and undertreated disease, with an added negative impact in terms of follow-up during the Covid-19 pandemic, since 91.7% considered that it had not been adequate. 47% of the participants did not know the CEAP classification and 56.3% did not know the venous clinical severity scale (VCSS). 92.7% of physicians prescribed compression stockings and 74.7% phlebotonic drugs. Hidrosmine was the best known and most prescribed venoactive drug (51.7%). 73% of the doctors recognized that they did not use any algorithm or protocol for the diagnosis, treatment and monitoring of CVD in their usual clinical practice and 91% stated that they were not trained in their workplaces. 54.3% of the physicians believed that one of the main limitations that made follow-up of the disease difficult was the lack of coordination with the vascular surgeons.
    Conclusions: Updating and responding to the training needs of professionals regarding CVD is essential to guarantee quality care continuity in the care of our patients.
    MeSH term(s) Female ; Humans ; Male ; Middle Aged ; Chronic Disease ; Cross-Sectional Studies ; Delivery of Health Care ; Pandemics ; Spain/epidemiology ; Vascular Diseases/diagnosis ; Vascular Diseases/epidemiology ; Vascular Diseases/therapy
    Language Spanish
    Publishing date 2023-08-22
    Publishing country Spain
    Document type English Abstract ; Journal Article ; Observational Study
    ISSN 1578-8865
    ISSN (online) 1578-8865
    DOI 10.1016/j.semerg.2023.102063
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: COVID-19 y tromboprofilaxis: recomendaciones para nuestra práctica clínica en Atención Primaria.

    Piera Carbonell, A / Frías Vargas, M / García Vallejo, O / García Lerín, A / Cabrera Ferriols, M A / Peiró Morant, J / Carrasco Carrasco, E

    Semergen

    2020  Volume 46, Issue 7, Page(s) 479–486

    Abstract: The new coronavirus (SARS-CoV-2) is responsible for a severe acute respiratory syndrome. Among its manifestations, it can develop a thrombotic disease, both venous and arterial, due to excessive inflammation that affects the vascular system, with ... ...

    Title translation COVID-19 and thromboprophylaxis: Recommendations for our clinical practice in Primary Care.
    Abstract The new coronavirus (SARS-CoV-2) is responsible for a severe acute respiratory syndrome. Among its manifestations, it can develop a thrombotic disease, both venous and arterial, due to excessive inflammation that affects the vascular system, with platelet activation and endothelial dysfunction, among other mechanisms. Thrombosis is associated with SARS-CoV-2 infection, increasing its severity and conferring a worse prognosis. Our performance as Family Physicians can contribute important actions in the management and control of this severe complication. Considering that many of our patients already receive antithrombotic or anticoagulant therapy, the fact that they may develop a COVID-19 infection will have implications for the choice, dosage and control of their treatment. In this document we review, with the information currently available, the relationship between disease caused by SARS-CoV-2 and thrombosis, as well as its management with a focus on Primary Care.
    MeSH term(s) Anticoagulants/administration & dosage ; Anticoagulants/therapeutic use ; Betacoronavirus ; COVID-19 ; Coronavirus Infections/complications ; Coronavirus Infections/diagnosis ; Coronavirus Infections/therapy ; Family Practice/methods ; Humans ; Pandemics ; Pneumonia, Viral/complications ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/therapy ; Primary Health Care/methods ; Risk Assessment ; SARS-CoV-2 ; Thrombosis/prevention & control ; Thrombosis/virology ; Venous Thromboembolism/prevention & control ; Venous Thromboembolism/virology
    Chemical Substances Anticoagulants
    Keywords covid19
    Language Spanish
    Publishing date 2020-09-18
    Publishing country Spain
    Document type Consensus Development Conference ; Journal Article ; Practice Guideline
    ISSN 1578-8865
    ISSN (online) 1578-8865
    DOI 10.1016/j.semerg.2020.07.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Disnea como síntoma de alarma. Importancia de la atención primaria en un nuevo modelo de atención a pacientes COVID-19.

    Peiró Morant, J F / Frías Vargas, M / Piera Carbonell, A / García Vallejo, O / Carrasco Carrasco, E

    Semergen

    2020  Volume 47, Issue 1, Page(s) 59–61

    Title translation Dyspnea as an alarm symptom. Importance of primary care in a new model of care for COVID-19 patients.
    MeSH term(s) COVID-19/complications ; COVID-19/diagnosis ; COVID-19/therapy ; COVID-19 Testing/methods ; Dyspnea/virology ; Humans ; Male ; Middle Aged ; Primary Health Care/methods ; Pulmonary Embolism/diagnostic imaging ; Pulmonary Embolism/virology ; Tomography, X-Ray Computed
    Language Spanish
    Publishing date 2020-07-01
    Publishing country Spain
    Document type Case Reports ; Letter
    ISSN 1578-8865
    ISSN (online) 1578-8865
    DOI 10.1016/j.semerg.2020.06.015
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: COVID-19 y tromboprofilaxis: recomendaciones para nuestra práctica clínica en Atención Primaria./ [COVID-19 and thromboprophylaxis: Recommendations for our clinical practice in Primary Care]

    Piera Carbonell, A / Frías Vargas, M / García Vallejo, O / García Lerín, A / Cabrera Ferriols, M A / Peiró Morant, J / Carrasco Carrasco, E

    SEMERGEN, Soc. Esp. Med. Rural Gen. (Ed. Impr.)

    Abstract: The new coronavirus (SARS-CoV-2) is responsible for a severe acute respiratory syndrome. Among its manifestations, it can develop a thrombotic disease, both venous and arterial, due to excessive inflammation that affects the vascular system, with ... ...

    Abstract The new coronavirus (SARS-CoV-2) is responsible for a severe acute respiratory syndrome. Among its manifestations, it can develop a thrombotic disease, both venous and arterial, due to excessive inflammation that affects the vascular system, with platelet activation and endothelial dysfunction, among other mechanisms. Thrombosis is associated with SARS-CoV-2 infection, increasing its severity and conferring a worse prognosis. Our performance as Family Physicians can contribute important actions in the management and control of this severe complication. Considering that many of our patients already receive antithrombotic or anticoagulant therapy, the fact that they may develop a COVID-19 infection will have implications for the choice, dosage and control of their treatment. In this document we review, with the information currently available, the relationship between disease caused by SARS-CoV-2 and thrombosis, as well as its management with a focus on Primary Care.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #779632
    Database COVID19

    Kategorien

  6. Article: [COVID-19 and thromboprophylaxis: Recommendations for our clinical practice in Primary Care]

    Piera Carbonell, A. / Frías Vargas, M. / García Vallejo, O. / García Lerín, A. / Cabrera Ferriols, M. A. / Peiró Morant, J. / Carrasco Carrasco, E.

    Semergen

    Abstract: The new coronavirus (SARS-CoV-2) is responsible for a severe acute respiratory syndrome Among its manifestations, it can develop a thrombotic disease, both venous and arterial, due to excessive inflammation that affects the vascular system, with platelet ...

    Abstract The new coronavirus (SARS-CoV-2) is responsible for a severe acute respiratory syndrome Among its manifestations, it can develop a thrombotic disease, both venous and arterial, due to excessive inflammation that affects the vascular system, with platelet activation and endothelial dysfunction, among other mechanisms Thrombosis is associated with SARS-CoV-2 infection, increasing its severity and conferring a worse prognosis Our performance as Family Physicians can contribute important actions in the management and control of this severe complication Considering that many of our patients already receive antithrombotic or anticoagulant therapy, the fact that they may develop a COVID-19 infection will have implications for the choice, dosage and control of their treatment In this document we review, with the information currently available, the relationship between disease caused by SARS-CoV-2 and thrombosis, as well as its management with a focus on Primary Care
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #850665
    Database COVID19

    Kategorien

  7. Article ; Online: COVID-19 y tromboprofilaxis

    Piera Carbonell, A. / Frías Vargas, M. / García Vallejo, O. / García Lerín, A. / Cabrera Ferriols, M.A. / Peiró Morant, J. / Carrasco Carrasco, E.

    Medicina de Familia. SEMERGEN

    recomendaciones para nuestra práctica clínica en Atención Primaria

    2020  Volume 46, Issue 7, Page(s) 479–486

    Keywords Family Practice ; Public Health, Environmental and Occupational Health ; covid19
    Language Spanish
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    ISSN 1138-3593
    DOI 10.1016/j.semerg.2020.07.007
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top